Genmab A/S (GMAB)

Genmab Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Genmab stock have an average target of 40, with a low estimate of 27 and a high estimate of 50. The average target predicts an increase of 105.13% from the current stock price of 19.50.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$27	$40	$45	$50
Change	+38.46%	+105.13%	+130.77%	+156.41%

Analyst Ratings

The average analyst rating for Genmab stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	3	3	3	3	3	3
Buy	2	2	2	2	3	4
Hold	2	2	2	2	2	2
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	9	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Maintains $50 → $45	Strong Buy	Maintains	$50 → $45	+130.77%	Mar 11, 2025
Matt Phipps William Blair	William Blair	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Mar 11, 2025
Jonathan Chang Leerink Partners	Leerink Partners	Hold → Buy Upgrades $27	Hold → Buy	Upgrades	$27	+38.46%	Feb 13, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+156.41%	Jan 23, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $50	Strong Buy	Maintains	$50	+156.41%	Jan 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

25.79B

Increased by 19.81%

from 21.53B

Revenue Next Year

29.39B

Increased by 13.94%

from 25.79B

EPS This Year

102.20

Decreased by -15.79%

from 121.36

EPS Next Year

126.71

Increased by 23.98%

from 102.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	10.11B	8.42B	14.51B	16.47B	21.53B	25.79B	29.39B	31.55B
Revenue Growth	88.43%	-16.75%	72.33%	13.58%	30.67%	19.81%	13.94%	7.38%
EPS	72.21	44.77	82.59	66.02	121.36	102.20	126.71	167.36
EPS Growth	112.20%	-38.00%	84.48%	-20.06%	83.82%	-15.79%	23.98%	32.08%
Forward PE	-	-	-	-	-	1.32	1.06	0.80
No. Analysts	-	-	-	-	-	27	23	15

Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	27.8B	32.5B	37.9B
Avg	25.8B	29.4B	31.6B
Low	23.5B	25.1B	2.7B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	29.4%	25.9%	29.0%
Avg	19.8%	13.9%	7.4%
Low	9.0%	-2.6%	-90.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	139.40	184.28	260.31
Avg	102.20	126.71	167.36
Low	57.17	75.96	137.44

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	14.9%	80.3%	105.4%
Avg	-15.8%	24.0%	32.1%
Low	-52.9%	-25.7%	8.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.